Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04214756 · ClinicalTrials.gov registry record
Methodist Acute Pancreatitis Protocol
A clinical trial of Acute Pancreatitis (AP), sponsored by Methodist Health System.
- Active
- Registry status
- 500
- Enrollment target
- 1
- Study location
NCT04214756: Active study of Acute Pancreatitis (AP), sponsored by Methodist Health System.
NCT04214756 is a study of Acute Pancreatitis (AP) that is active but no longer recruiting, run by Methodist Health System. The registered enrollment target is 500 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04214756, a study of Acute Pancreatitis (AP), is active but no longer recruiting, sponsored by Methodist Health System.
- ACTIVE NOT RECRUITING
- Registry status
- 500 participants
- Enrollment target
- 1
- Study location
Study Summary
The overall goal of this ongoing registry study is to optimize initial evaluation and treatment of patients with AP according to recommended guidelines, the Methodist Acute Pancreatitis Protocol (MAPP), which were implemented in January 2015.
Primary Outcome
Length of hospital stay will be calculated in days with a discrete variable as \[(discharge date - Admission date)\].
Conditions Studied
Interventions
- PROCEDURE Acute Pancreatitis
Study Locations (1)
Texas
- Methodist Health System - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2014-04-05 |
| Est. Completion | 2026-06 |
What the registry record for NCT04214756 still lists
NCT04214756 is an observational study that tracks outcomes without assigning an intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Acute Pancreatitis (AP) appearing as the primary indexed condition, and to 1 intervention - of which Acute Pancreatitis is the first listed.
NCT04214756 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT04214756 about?
NCT04214756 is a clinical study titled "Methodist Acute Pancreatitis Protocol". The overall goal of this ongoing registry study is to optimize initial evaluation and treatment of patients with AP according to recommended guidelines, the Methodist Acute Pancreatitis Protocol (MAPP), which were implemented in January 2015.
What is the current status of trial NCT04214756?
This trial is currently active not recruiting. The enrollment target is 500 participants. The study started on 2014-04-05. Estimated completion is 2026-06.
What conditions does trial NCT04214756 study?
This clinical trial studies the following conditions: Acute Pancreatitis (AP).
What interventions are being tested in trial NCT04214756?
The interventions under investigation include: Acute Pancreatitis (PROCEDURE).
Who is sponsoring clinical trial NCT04214756?
This trial is sponsored by Methodist Health System, which has 125 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04214756 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI